Structure-based drug design of novel and highly potent pyruvate dehydrogenase kinase inhibitors.
Bessho Y, Akaki T, Hara Y, Yamakawa M, Obika S, Mori G, Ubukata M, Yasue K, Nakane Y, Terasako Y, Orita T, Doi S, Iwanaga T, Fujishima A, Adachi T, Ueno H, Motomura T.
Bessho Y, et al. Among authors: ubukata m.
Bioorg Med Chem. 2021 Dec 15;52:116514. doi: 10.1016/j.bmc.2021.116514. Epub 2021 Nov 10.
Bioorg Med Chem. 2021.
PMID: 34808405